A study failed to show significant cognitive benefits with exercise over 2 years, but the rewards are more likely to manifest ...
Surfshark, a leading VPN provider, is revolutionizing the consumer VPN industry with the launch of its own VPN protocol, Dausos. While traditional VPNs consolidate all user traffic through a single ...
MedPage Today on MSN
Strategy Reduces Inappropriate Proton Pump Inhibitor Use
Patient- and physician-facing interventions together doubled the reductions in PPI use ...
Warren Buffett's simple "market closure test" reveals why millions of stressed retail investors are doing investing wrong.
When IVUS did not outperform angiography for guiding percutaneous interventions in two trials, the results offered more questions than answers.
After Replimune’s advanced melanoma drug was rejected for a second time, CEO Sushil Patel slammed the FDA for failing to ...
A Cochrane Review finds aspirin likely results in little to no difference in colorectal cancer incidence at a follow-up of 5 ...
Lyell Immunopharma, Inc. (LYEL) 25th Annual Needham Virtual Healthcare Conference April 14, 2026 11:00 AM EDTCompany ParticipantsLynn Seely - ...
New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI's unmatched durability in wet AMD with sustained disease control AXPAXLI demonstrated robust CSFT control with a median time of 39 weeks ...
In an interview with Targeted Oncology, Naomi Haas, MD, discusses the evolving landscape of adjuvant and neoadjuvant immune ...
A groundbreaking study in genetics education examines the relationship between the quality of genetics education and the ...
The risks and benefits of hormone replacement therapy use for menopausal symptoms in breast cancer survivors are examined in light of recent research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results